A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects
Status:
Withdrawn
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to assess the safety, pharmacokinetics and
pharmacodynamics of BMS-707035 in subjects infected with HIV-1
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-707035 HIV Integrase Inhibitors Integrase Inhibitors